Tumor cell AMPK activation enhances NK cell anti-tumor immunity and synergizes with PD-L1 blockade therapy
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Metabolism
Diabetes
and Cancer
Immune Cell Function and Interaction
Publication details
- Journal / source
- Molecular Therapy
- Publisher
- Elsevier BV
- Volume
- 34
- Issue
- 5
- Pages
- 2678–2691
- Publication date
- 29 January 2026
- Language
- EN